trial
as of 2026-07-01Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional Regulation
NCTId NCT06936397
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2025-03-15
Primary completion
2025-08-15
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Sponsors
Beykoz UniversityLead Sponsor
Uskudar UniversityCollaborator
Istanbul Nisantasi UniversityCollaborator
Investigators
3
Gökben Hızlı Sayar, ProfessorStudy Chair
Selami Varol Ülker, PhdStudy Director
Metin Çınaroğlu, PhdPrincipal Investigator
Sites
1 total
Istanbul, Turkey (Türkiye)
Facts & assertions
4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2025-08-15
Status
RECRUITING
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
company
indication
investigator